Living with non-Hodgkin lymphoma can be challenging, but there are care options available that may help.
DLBCL is one of the most common types of non-Hodgkin lymphoma. The outlook for DLBCL can vary depending on factors like the person’s age, overall health, and the stage of the disease. With treatment, and depending on the stage, people with DLBCL can achieve remission (reduced symptoms) or even be cured.
MCL is a relatively rare type of non-Hodgkin lymphoma. While MCL can be challenging to treat, advances in treatment have improved outcomes for many people, and some can achieve long-term remission.
Your experience with diffuse large B-cell lymphoma (DLBCL) may help improve health outcomes for you and others living with the disease.
This clinical research study will test the study drug to see how well it works for treating your DLBCL when combined with other drugs. You may be eligible to participate in the study if:
You have been diagnosed with DLBCL
You have not received any form of treatment for this condition
You are between the ages of 18-80 years old
Your experience with mantle cell lymphoma (MCL) may help improve health outcomes for you and future generations.
This clinical research study will test the study drug to see how well it works in treating your MCL compared to other drugs. You may be eligible to participate in the study if:
You have been diagnosed with MCL
Your cancer has returned after a period of remission or in a refractory period (not responding to any form of treatment)
You are 18 years or older
When we are included in clinical research for blood and bone marrow cancer(s) or any other condition, we can understand how safe and effective new treatments can be for us.
By participating in clinical research, we have the opportunity to build a healthier Black community.
If you still have questions, you are not alone.
NOWINCLUDED, powered by Acclinate, is a community created for us to: